还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

) {' _+ |: ~! ~. s+ {请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
' p1 u9 A% Y( N  L1 }- z
) f8 B5 d3 c3 d0 e
, v( G1 v8 F5 N8 z( M9 P6 {Sub-category:
8 g9 I* V' x" z9 V/ rMolecular Targets


7 [  @: e1 A2 p/ m$ HCategory:
Tumor Biology
9 [6 A! H! S) I
3 C8 y- |( ~2 [2 Z$ P8 T& u
Meeting:
, T3 {& I; }7 e, b2011 ASCO Annual Meeting

) g$ h# b9 {& R5 @( _/ ^
, A2 J# _: u, ~. h0 O6 dSession Type and Session Title:
Poster Discussion Session, Tumor Biology

/ Q3 ^9 d5 W' U4 J8 ]5 J5 n% T0 Q
Abstract No:
10517
. L% f. j* Q$ B/ a; ?3 G
% s/ @6 A2 |: V. Y) F% C7 o
" N* I  k. U! E' X0 h5 lCitation:
) t, I* W' X1 L. a; Z$ }; f/ zJ Clin Oncol 29: 2011 (suppl; abstr 10517)


( H2 }+ F: D# j+ K) f. k4 p! DAuthor(s):
J. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
+ I) K! y1 R. Q6 p
% e: u8 H# V! _* T( Y
7 m: R. A& H9 C7 R3 P2 i
. R" s& X+ R: FAbstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
9 {4 T2 |# v. D
7 e( \% S7 [3 U) |! h6 zAbstract Disclosures

Abstract:

' s: y4 X# {* n" c$ _9 _
% [; B* w- ^7 V# H: gBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
+ q% k& S/ f* K- a, n0 j( b
  g: e5 e1 h* M0 H  i
) ^) j( Y9 ], {' ?) N2 B7 N

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

: `) i. ]) I& R4 t; h0 k平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
6 I) v9 A5 c2 U
- D9 D! h( Y0 K" ^2 _& o, c9 `) q2 H现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊